Blockage of Ca2+-permeable AMPA receptors suppresses proliferation of schwannoma cells
RNA-seq (gene expression) · human · 9 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 9 samples: 9 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE335945_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1479987 and SRA study SRP710908. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 9 sample titles: 9 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9824075 TIG-1 cells, control
- GSM9824076 TIG-1 cells, 10uM PER, day7
- GSM9824077 TIG-1 cells, 30uM PER, day7
- GSM9824078 YST-1 cells, control
- GSM9824079 YST-1 cells, 10uM PER, day7
- GSM9824080 YST-1 cells, 30uM PER, day7
- GSM9824081 HS-PSS cells, control
- GSM9824082 HS-PSS cells, 10uM PER, day7
- GSM9824083 HS-PSS cells, 30uM PER, day7
- GSE253677 EMILIN1 suppresses cell proliferation by inactivating Aurora Kinase and cell cycle regulator in head and neck squamous cell carcinoma 36 samples shares proliferation, suppresses
- GSE268609 A roadmap to human hippocampal neurogenesis in adulthood, aging and AD 78 samples shares ampa
- GSE282456 IRX2 and NPTX1 differential regulation of b-catenin underlies MEK-mediated proliferation in human neuroglial cells 40 samples shares proliferation
- GSE292071 A Single-cell Atlas of Schwannoma Across Genetic Backgrounds and Anatomic Locations 151 samples shares schwannoma
- GSE271737 Glucocorticoid Receptor Suppresses GATA6-Mediated RNA Polymerase II Pause Release to Modulate Classical Subtype Identity in Pancreatic Cancer 110 samples shares suppresses
- GSE246371 An environmentally relevant mixture of Perfluoroalkyl Substances (PFAS) impacts proliferation, steroid hormone synthesis, and gene transcription in primary human granulosa cells 12 samples shares proliferation
- GSE286315 HOXC4 Promotes Proliferation of Endometriotic Stromal Cells via the SLIT2-ROBO1 Axis 12 samples shares proliferation
- GSE241046 miR-BART1-3p inhibits proliferation and invasion of gastric cancer cells by regulating STAT3/pSTAT3 and PI3K/AKT/pAKT signaling pathways 12 samples shares proliferation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.